Nav: Home

Exposure to high-frequency electromagnetic fields at work not associated with brain tumors

July 31, 2018

No clear associations were found between occupational exposure to high frequency electromagnetic fields (EMF) and risk of glioma or meningioma, in one of the largest epidemiological studies performed to date and led by ISGlobal, an institution supported by "la Caixa" Foundation. However, the findings highlight the need for further research on radiofrequency magnetic fields and tumour promotion, as well as possible interactions with other frequencies and with chemicals.

High frequency electromagnetic fields are a form of non-ionising radiation and comprise intermediate frequency (3kHz-10MHz) and radiofrequency (10MHz-300 GHz). Based on limited animal and epidemiological evidence, they were declared by WHO's International Agency for Research on Cancer (IARC) in 2011 as possibly carcinogenic to humans, but few recent studies have provided further evidence regarding exposure at work. "This is the largest study of brain tumours and occupational high-frequency EMF exposure to date", explains senior author Elisabeth Cardis, Head of the Radiation Programme at ISGlobal.

The researchers developed a 'source-exposure matrix' based on measurements collected from the literature for EMF sources reported by the study participants. With this tool plus detailed individual data, they estimated individual RF and IF exposure at work and analysed the possible association with risk of glioma or meningioma, two of the most frequent brain tumours in adults. The INTEROCC study, performed under the umbrella of INTERPHONE, and supported by the European project GERoNiMO, comprised 2,054 glioma cases, 1,924 meningioma cases and 5,601 controls from seven countries. Occupational sectors that involved exposure to electromagnetic fields included working with or near radars, telecommunication antennas, medical diagnosis and treatment and microwave drying ovens, among others.

Despite the major improvements in estimating exposure, this large case-control study provided no clear evidence for a positive association between cumulative high-frequency EMF exposure and glioma or meningioma risk. However, the number of exposed participants was small: only 10% of the participants were exposed to radiofrequencies and less than 1% were exposed to intermediate frequencies, which limited the statistical power to find clear associations, if they exist.

"Our individualised exposure assessment approach is an important improvement over previous efforts to assess high-frequency EMF exposure risks. Although we did not find a positive association, the fact that we observed indication of an increased risk in the group with most recent radiofrequency exposure deserves further investigation," explains first author Javier Vila. "We also need to investigate possible interactions with other frequencies, and with chemicals," adds Cardis.
-end-


Barcelona Institute for Global Health (ISGlobal)

Related Glioma Articles:

Surprising link between blood sugar and brain cancer found
New research further illuminates the surprising relationship between blood sugar and brain tumors and could begin to shed light on how certain cancers develop.
Feinstein Institute examines use of antiparasitic drug as new treatment for brain tumors
Marc Symons, PhD, professor at the Feinstein Institute for Medical Research is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers.
Method identified to boost detection of highly cancerous stem cells
Tokyo Medical and Dental University (TMDU)-led researchers discovered a subpopulation of highly cancerous stem cells in a brain cancer cell line.
Case comprehensive cancer center analyzes brain tumor data, doubles known risk factors for glioma
A massive new study involving blood samples from over 30,000 individuals has identified 13 new genetic risk factors for glioma, the most common type of malignant brain tumor in adults.
New genetic risk factors identify 2 distinct glioma subtypes
An international consortium of researchers led by Dr. Melissa Bondy, professor of medicine at Baylor College of Medicine, has conducted the largest study to date of malignant brain tumors looking for genetic markers of glioma, a highly aggressive form of brain cancer.
More Glioma News and Glioma Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Teaching For Better Humans
More than test scores or good grades — what do kids need to prepare them for the future? This hour, guest host Manoush Zomorodi and TED speakers explore how to help children grow into better humans, in and out of the classroom. Guests include educators Olympia Della Flora and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#535 Superior
Apologies for the delay getting this week's episode out! A technical glitch slowed us down, but all is once again well. This week, we look at the often troubling intertwining of science and race: its long history, its ability to persist even during periods of disrepute, and the current forms it takes as it resurfaces, leveraging the internet and nationalism to buoy itself. We speak with Angela Saini, independent journalist and author of the new book "Superior: The Return of Race Science", about where race science went and how it's coming back.